Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
30.22
-1.06 (-3.39%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 30.18 - 31.36
52 week 18.63 - 31.50
Open 31.09
Vol / Avg. 206,299.00/203,961.00
Mkt cap 654.20M
P/E 42.67
Div/yield     -
EPS 0.71
Shares 21.65M
Beta 1.50
Inst. own 84%
Feb 10, 2015
Q4 2014 Cynosure Inc Earnings Release - 9:30AM EST - Add to calendar
Feb 10, 2015
Q4 2014 Cynosure Inc Earnings Call - 9:00AM EST - Add to calendar
Jan 13, 2015
Cynosure Inc at Needham Growth Conference
Nov 20, 2014
Cynosure Inc. at Canaccord Genuity Medical Technologies & Diagnostics Forum - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 4.30% -0.73%
Operating margin 7.34% -2.58%
EBITD margin - 15.48%
Return on average assets 2.86% -0.51%
Return on average equity 3.66% -0.63%
Employees 576 -
CDP Score - -

Address

5 Carlisle Road
WESTFORD, MA 01886
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cynosure Inc. (Cynosure develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis. The Company has also developed an aesthetic treatment product for the home use market. The Company�s product portfolio is composed of a range of energy sources including Alexandrite, diode, Nd:YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. The Company�s product line includes, Elite, Affirm/SmartSkin, Cynergy and Accolade.

Officers and directors

Michael R. Davin Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy W. Baker President, Chief Financial Officer, Chief Operating Officer, Treasurer
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas J. Delaney Executive Vice President - Worldwide Sales
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William O. Flannery Lead Director
Age: 68
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 70
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 55
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 48
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 55
Bio & Compensation  - Reuters